AAAAAA

   
Results: 1-14 |
Results: 14

Authors: OREGAN RM CISNEROS A ENGLAND GM MACGREGOR JI MUENZNAR HD ASSIKIS VJ BILIMORIA MM PIETTE M DRAGAN YP PITOT HC CHATTERTON R JORDAN VC
Citation: Rm. Oregan et al., EFFECTS OF THE ANTIESTROGENS TAMOXIFEN, TOREMIFENE, AND ICI-182,780 ON ENDOMETRIAL CANCER GROWTH, Journal of the National Cancer Institute, 90(20), 1998, pp. 1552-1558

Authors: VITZTHUM VJ BENTLEY GR SPIELVOGEL H CACERES E HEIDELBERG K CRONE K CHATTERTON R
Citation: Vj. Vitzthum et al., SALIVARY PROGESTERONE LEVELS AT CONCEPTION AND DURING GESTATION IN RURAL BOLIVIAN WOMEN, The FASEB journal, 12(5), 1998, pp. 4211-4211

Authors: MILAD MP KLOCK SC MOSES S CHATTERTON R
Citation: Mp. Milad et al., STRESS AND ANXIETY DO NOT RESULT IN PREGNANCY WASTAGE, Human reproduction (Oxford. Print), 13(8), 1998, pp. 2296-2300

Authors: CHATTERTON R STEDMAN T
Citation: R. Chatterton et T. Stedman, EXPERIENCES WITH CLOZAPINE AND OLANZAPINE, Australian and New Zealand Journal of Psychiatry, 32(3), 1998, pp. 463-463

Authors: GANN P CHATTERTON R VOGELSONG K DUPUIS J ELLMAN A
Citation: P. Gann et al., MITOGENIC GROWTH-FACTORS IN BREAST FLUID OBTAINED FROM HEALTHY WOMEN - EVALUATION OF BIOLOGICAL AND EXTRANEOUS SOURCES OF VARIABILITY, Cancer epidemiology, biomarkers & prevention, 6(6), 1997, pp. 421-428

Authors: CHATTERTON R MCGRATH J
Citation: R. Chatterton et J. Mcgrath, AN OPEN-LABEL ASSESSMENT OF THE IMPACT OF CLOZAPINE ON BIOLOGICAL, PSYCHOSOCIAL AND ECONOMIC VARIABLES, Schizophrenia research, 24(1-2), 1997, pp. 186-186

Authors: GANN PH CHATTERTON R VOGELSONG K GRAYHACK JT LEE C
Citation: Ph. Gann et al., EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES IN HUMAN PROSTATIC FLUID - SOURCES OF VARIABILITY IN ASSAY RESULTS, The Prostate, 32(4), 1997, pp. 234-240

Authors: CHATTERTON R
Citation: R. Chatterton, EOSINOPHILIA AFTER COMMENCEMENT OF CLOZAPINE TREATMENT, Australian and New Zealand Journal of Psychiatry, 31(6), 1997, pp. 874-876

Authors: CHATTERTON R CARDY S SCHRAMM MT
Citation: R. Chatterton et al., NEUROLEPTIC MALIGNANT SYNDROME AND CLOZAPINE MONOTHERAPY - RESPONSE, Australian and New Zealand Journal of Psychiatry, 31(3), 1997, pp. 435-436

Authors: MURILLO G KAMATH SK CHATTERTON R AMIN D ALEKEL L
Citation: G. Murillo et al., SEX-HORMONES AND BODY-COMPOSITION IN INDIAN AND PAKISTAN VERSUS CAUCASIAN PREMENOPAUSAL WOMEN, The FASEB journal, 10(3), 1996, pp. 1215-1215

Authors: CHATTERTON R CARDY S SCHRAMM TM
Citation: R. Chatterton et al., NEUROLEPTIC MALIGNANT SYNDROME AND CLOZAPINE MONOTHERAPY, Australian and New Zealand Journal of Psychiatry, 30(5), 1996, pp. 692-693

Authors: CHATTERTON R
Citation: R. Chatterton, SERUM CLOZAPINE ASSAY - COST-EFFECTIVE CLINICAL-ASSESSMENT TOOL, Schizophrenia research, 15(1-2), 1995, pp. 145-146

Authors: CHATTERTON R
Citation: R. Chatterton, CLOZAPINE SIDE-EFFECT PROFILE DURING THE FIRST 18 WEEKS OF TREATMENT, Schizophrenia research, 15(1-2), 1995, pp. 206-206

Authors: GREEN D CHATTERTON R HARRIS S GROSSMAN A HECHTER O
Citation: D. Green et al., RELATIONSHIP OF ADRENAL-STEROIDS TO THE PROGRESSION OF HIV-INFECTION IN HEMOPHILIACS, Blood, 86(10), 1995, pp. 3710-3710
Risultati: 1-14 |